Evidence map›Paper›PMID 35083047›Full record

ArticleSAGE open medical case reports2022

Demons syndrome with pericardial effusion followed by intensive care unit-acquired weakness: A case report and literature review.

Eri Obata, Kentaro Kai, Saki Aso, Nao Tsukamoto, Takuya Hanaoka, Yusuke Nabeta, Yasushi Kawano

Open access · goldAbstract readCase Reports
In one paragraph

Article in SAGE open medical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. IL-1βCell death discovery · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eri ObataDepartment of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan.ORCID https://orcid.org/0000-0003-2340-8482
Kentaro KaiDepartment of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan.
Saki AsoDepartment of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan.
Nao TsukamotoAdvanced Trauma, Emergency and Critical Care Center, Oita University Hospital, Oita, Japan.
Takuya HanaokaDepartment of Neurology, Faculty of Medicine, Oita University, Oita, Japan.
Yusuke NabetaAdvanced Trauma, Emergency and Critical Care Center, Oita University Hospital, Oita, Japan.
Yasushi KawanoDepartment of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan.
Oita University · JPOita University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Demons syndrome is defined by hydrothorax and ascites associated with a benign genital tumor that resolves after resection of the tumor. However, Demons syndrome with pericardial effusion has never been reported. Intensive care unit-acquired weakness is a neurological sequela to sepsis/systemic inflammatory response syndrome, or multi-organ failure. A 47-year-old, nulligravid, Japanese woman, was transferred to our hospital for refractory heart failure and a ruptured ovarian tumor. She had an 11-cm left ovarian tumor with ascites, hydrothorax, and pericardial effusion; she was intubated for pulmonary hypertension and admitted to the intensive care unit for septic shock. Four days later, a left salpingo-oophorectomy was performed for Demons syndrome with pericardial effusion. The histological diagnosis indicated a serous cystadenoma with fibrotic changes. Following surgery, ventilator weaning was delayed due to intensive care unit-acquired weakness. The association between Demons syndrome and pericardial effusion should be recognized to ensure early treatment and for preventing sequalae from the disease.

Indexed as

Demons syndromeintensive care unit–acquired weaknessMeigs syndromemyopathyparaneoplastic syndromepericardial effusion

Identifiers

PMID35083047
PMCPMC8784908
OpenAlexW4205848752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.